CurveBeam AI Limited (ASX: CVB) - Share Price
Current share price for CVB : $0.018 0.002 (10%)+
CurveBeam AI Limited (CVB) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It develops, manufactures and sells medical imaging (CT) scanners, coupled with AI SaaS-based clinical assessment solutions, to support medical practitioners in the management of musculoskeletal conditions. The Company's flagship CT scanner, HiRise, performs weight bearing CT scans as well as traditional non weight bearing CT scans, providing a range of advantages over the use of traditional CT or MRI devices.
CVB General Information +
| ASX Code | CVB |
| Website | http://curvebeamai.com |
| Industry/Sector | Health Care Equipment |
| Market Cap ($M) | 8 |
| CVB Share Price | $0.018 |
| Day High | $0.020 |
| Day Low | $0.018 |
| Last Close | $0.020 |
| CVB Share Price Movement | $0.00 ( 10% ) |
Prices as at 16:40, 28 Aug 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
CurveBeam AI Limited (CVB) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|
See all dividends from CurveBeam AI Limited (CVB) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
CurveBeam AI Limited (CVB) price-sensitive announcements
CVB - Quarterly Activities/Appendix 4C Cash Flow Report
CurveBeam AI Limited, listed on the ASX as CVB, reported its financial and operational act
CurveBeam AI Limited (CVB)
8 Jul 2026 | 9:33 AM
8 Jul 2026 | 9:33 AM
CVB - CVB Secures 5M Placement & Announces SPP
CurveBeam AI Limited, listed on the ASX, has secured a $5 million institutional and relate
CurveBeam AI Limited (CVB)
8 Jul 2026 | 9:29 AM
8 Jul 2026 | 9:29 AM
CVB - Trading Halt
On July 6, 2026, CurveBeam AI Limited announced a trading halt on its securities on the Au
CurveBeam AI Limited (CVB)
6 Jul 2026 | 9:09 AM
6 Jul 2026 | 9:09 AM
CVB - Q3 FY26 Quarterly Results Investor Webinar
During the Q3 FY26 Quarterly Results Investor Webinar, CurveBeam AI Limited reported recei
CurveBeam AI Limited (CVB)
30 Apr 2026 | 8:14 AM
30 Apr 2026 | 8:14 AM
CurveBeam AI Limited (CVB) Recent ASX Announcements
CVB Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2025A | -$16.90 | -$4.50 | -43.90% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2024A | -$23.66 | -$8.00 | -85.60% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2023A | -$32.30 | -$55.70 | 1,758.00% | 0.00 | 0.00 | 0.00% | 0.0% |
CVB Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | ||
| Cochlear Limited (COH) | $9,009M | -0.3136 | 0.2540 | 0.0785 | 33.5386 | 26.7454 | 24.7988 | 2.50% | 2.60% | 2.83% |
| CurveBeam AI Limited (CVB) | $10M | -0.4391 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Fisher & Paykel Healthcare Corporation Limited (FPH) | $21,407M | 0.1388 | 0.1653 | 0.1748 | 55.1187 | 47.3008 | 40.2629 | 1.19% | 1.29% | 1.45% |
| ResMed Inc. (RMD) | $19,154M | 9.5922 | 0.0985 | 0.0885 | 21.0311 | 19.1453 | 17.5880 | 1.11% | 1.20% | 1.30% |
CVB Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.00 | 0.00 | 0.20 | 0.00 |
| Market | 0.35 | 13.30 | 1.17 | 0.85 |
| Sector | 0.63 | 20.90 | 1.72 | 3.04 |
CVB Directors
| Name | Position | Start Date |
|---|---|---|
| Mr Gregory Wayne Brown | Chief Executive Officer, Managing Director | 29 Oct 2014 |
| Mr Arun Singh | Chief Operating Officer, Chief Technology Officer, Executive Director, President | 13 Mar 2023 |
| Mr Robert Lilley | Non-Executive Chairman, Non-Executive Director | 16 Apr 2021 |
| Mr Hashan De Silva | Non-Executive Director | 1 Oct 2021 |
| Mr Patrick Fisher | Non-Executive Director | 19 Mar 2026 |
CurveBeam AI Limited (CVB) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 1 Jul 2026 | SINGH, Arun | Issued | Indirect Shares | 20,415 | $0.137 | $2,802.980 |
| 5 Dec 2025 | SINGH, Arun | Buy | Direct Shares | 408,415 | $0.072 | $29,518.000 |
| 14 Aug 2025 | SINGH, Arun | Issued | Direct Shares | 131,237 | $0.180 | $23,622.660 |
See all changes in directors' interest & trades for CurveBeam AI Limited (CVB) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
CVB Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in CurveBeam AI Limited (CVB). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 43,210,324 (10.99%) | Firetrail Investments Pty Ltd |
| 41,082,279 (10.45%) | Arun Singh |
| 34,362,059 (8.74%) | Pinnacle Investment Management Group Limited |
| 30,370,856 (7.72%) | Ilwella Pty Ltd |
| 21,857,867 (5.56%) | Karst Peak Capital Limited |
CVB Calendar of Events
| Date | Event |
|---|---|
| 26 February 2027 | Report (Interim) |
| 29 September 2026 | Report (Annual) |
| 31 August 2026 | Issued Shares |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
